The total investment of MERCK Nantong Life Science Center is approximately 80 million euros, covering an area of approximately 41000 square meters (approximately 62.5 acres), which will further consolidate Merck's leading position in China's biopharmaceutical industry in cell culture media products and related technical services, high-purity inorganic salts, and ready to use culture media. The establishment of this center confirms Merck's confidence in the Chinese market, as well as Merck's ambition to maintain strong growth in the research, application, and process solutions sectors of its life sciences business in China. In recent years, with the booming development of the Chinese pharmaceutical market and its important position in the global market, Merck's life sciences business will provide leading innovative products and services for the biopharmaceutical and life sciences industries, supporting the rapid development of the industry.
